163 related articles for article (PubMed ID: 29527177)
1. Key Inflammatory Processes in Human NASH Are Reflected in Ldlr
Morrison MC; Kleemann R; van Koppen A; Hanemaaijer R; Verschuren L
Front Physiol; 2018; 9():132. PubMed ID: 29527177
[No Abstract] [Full Text] [Related]
2. Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr-/-.Leiden Mice.
Morrison MC; Verschuren L; Salic K; Verheij J; Menke A; Wielinga PY; Iruarrizaga-Lejarreta M; Gole L; Yu WM; Turner S; Caspers MPM; Martínez-Arranz I; Pieterman E; Stoop R; van Koppen A; van den Hoek AM; Mato JM; Hanemaaijer R; Alonso C; Kleemann R
Hepatol Commun; 2018 Dec; 2(12):1513-1532. PubMed ID: 30556039
[TBL] [Abstract][Full Text] [Related]
3. Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.
Seidel F; Fluiter K; Kleemann R; Worms N; van Nieuwkoop A; Caspers MPM; Grigoriadis N; Kiliaan AJ; Baas F; Michailidou I; Morrison MC
Front Cell Neurosci; 2023; 17():1205261. PubMed ID: 37457817
[TBL] [Abstract][Full Text] [Related]
4. Translational characterization of the temporal dynamics of metabolic dysfunctions in liver, adipose tissue and the gut during diet-induced NASH development in Ldlr-/-.Leiden mice.
Gart E; van Duyvenvoorde W; Snabel JM; de Ruiter C; Attema J; Caspers MPM; Lek S; van Heuven BJ; Speksnijder AGCL; Giera M; Menke A; Salic K; Bence KK; Tesz GJ; Keijer J; Kleemann R; Morrison MC
Heliyon; 2023 Mar; 9(3):e13985. PubMed ID: 36915476
[TBL] [Abstract][Full Text] [Related]
5. Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells.
Gart E; van Duyvenvoorde W; Toet K; Caspers MPM; Verschuren L; Nielsen MJ; Leeming DJ; Souto Lima E; Menke A; Hanemaaijer R; Keijer J; Salic K; Kleemann R; Morrison MC
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944770
[TBL] [Abstract][Full Text] [Related]
6. Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model.
van Koppen A; Verschuren L; van den Hoek AM; Verheij J; Morrison MC; Li K; Nagabukuro H; Costessi A; Caspers MPM; van den Broek TJ; Sagartz J; Kluft C; Beysen C; Emson C; van Gool AJ; Goldschmeding R; Stoop R; Bobeldijk-Pastorova I; Turner SM; Hanauer G; Hanemaaijer R
Cell Mol Gastroenterol Hepatol; 2018; 5(1):83-98.e10. PubMed ID: 29276754
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the Transcriptional Dynamics of NASH Pathogenesis Affecting Atherosclerosis.
van den Hoek AM; Özsezen S; Caspers MPM; van Koppen A; Hanemaaijer R; Verschuren L
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897797
[TBL] [Abstract][Full Text] [Related]
8. Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice.
Morrison MC; Mulder P; Salic K; Verheij J; Liang W; van Duyvenvoorde W; Menke A; Kooistra T; Kleemann R; Wielinga PY
Int J Obes (Lond); 2016 Sep; 40(9):1416-23. PubMed ID: 27121255
[TBL] [Abstract][Full Text] [Related]
9. Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice.
Salic K; Kleemann R; Wilkins-Port C; McNulty J; Verschuren L; Palmer M
PLoS One; 2019; 14(6):e0218459. PubMed ID: 31233523
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
Lytle KA; Wong CP; Jump DB
PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
[TBL] [Abstract][Full Text] [Related]
11. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.
Loyer X; Paradis V; Hénique C; Vion AC; Colnot N; Guerin CL; Devue C; On S; Scetbun J; Romain M; Paul JL; Rothenberg ME; Marcellin P; Durand F; Bedossa P; Prip-Buus C; Baugé E; Staels B; Boulanger CM; Tedgui A; Rautou PE
Gut; 2016 Nov; 65(11):1882-1894. PubMed ID: 26338827
[TBL] [Abstract][Full Text] [Related]
12. A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
Schoemaker MH; Kleemann R; Morrison MC; Verheij J; Salic K; van Tol EAF; Kooistra T; Wielinga PY
PLoS One; 2017; 12(7):e0180648. PubMed ID: 28678821
[TBL] [Abstract][Full Text] [Related]
13. Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model.
Ipsen DH; Skat-Rørdam J; Tsamouri MM; Latta M; Lykkesfeldt J; Tveden-Nyborg P
Mol Genet Genomics; 2019 Jun; 294(3):649-661. PubMed ID: 30759275
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.
Nozaki Y; Fujita K; Wada K; Yoneda M; Kessoku T; Shinohara Y; Imajo K; Ogawa Y; Nakamuta M; Saito S; Masaki N; Nagashima Y; Terauchi Y; Nakajima A
BMC Gastroenterol; 2015 Apr; 15():42. PubMed ID: 25881230
[TBL] [Abstract][Full Text] [Related]
15. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
[TBL] [Abstract][Full Text] [Related]
16. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
[TBL] [Abstract][Full Text] [Related]
18. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
Lytle KA; Jump DB
PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
[TBL] [Abstract][Full Text] [Related]
19. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
[TBL] [Abstract][Full Text] [Related]
20. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
